Tag | Content |
---|
EnhancerAtlas ID | HS059-03026 |
Organism | Homo sapiens |
Tissue/cell | GM12878 |
Coordinate | chr1:160701750-160703840 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
EWSR1-FLI1 | MA0149.1 | chr1:160703744-160703762 | GGAAGGAAGGAACCAAGA | + | 7.14 | LMX1B | MA0703.2 | chr1:160703826-160703837 | TTAATTAAATT | - | 6.32 | NEUROD2 | MA0668.1 | chr1:160702536-160702546 | GCCATATGGT | + | 6.02 | NFAT5 | MA0606.1 | chr1:160703328-160703338 | ATTTTCCATT | + | 6.02 | NFATC1 | MA0624.1 | chr1:160703328-160703338 | ATTTTCCATT | + | 6.02 | NFATC3 | MA0625.1 | chr1:160703328-160703338 | ATTTTCCATT | + | 6.02 | ZNF263 | MA0528.1 | chr1:160703087-160703108 | GGAGGAGGAGGTAGAAGGTAG | + | 6.48 | ZNF263 | MA0528.1 | chr1:160703084-160703105 | GATGGAGGAGGAGGTAGAAGG | + | 6.88 |
|
| Number of super-enhancer constituents: 10 | ID | Coordinate | Tissue/cell |
SE_09701 | chr1:160701572-160703127 | CD14 | SE_09701 | chr1:160703133-160704434 | CD14 | SE_20347 | chr1:160703174-160704276 | CD56 | SE_22738 | chr1:160702765-160704438 | CD8_primiary | SE_32482 | chr1:160701571-160704691 | GM12878 | SE_43568 | chr1:160703298-160704821 | MM1S | SE_59576 | chr1:160676149-160715299 | Ly3 | SE_60836 | chr1:160676114-160703032 | DHL6 | SE_61553 | chr1:160673445-160704936 | Toledo | SE_67392 | chr1:160703298-160704821 | MM1S |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 2 | ID | Chromosome | Start | End |
GH01I160732 | chr1 | 160701970 | 160702334 | GH01I160733 | chr1 | 160703302 | 160704305 |
|
Enhancer Sequence | GTTTCTGGTT CTAGCTCCTT GAGGAATGGC CACACTGTCT TCCACAATGG TTGCACTAAC 60 TTACACTCAC ACCAACAGTG TAAAAGCATT CCTATTTCTC CACATCCTCT CCAGCATCTG 120 TTGTTTCCTG ACTTTTTAAT GATCACCATT CTAACCGGCA TGAGATAGTA TCTCCTTGTG 180 GTTTTGATTT GCATGAAATG CTGTTTTTAA AACTACACTA GTTGTTTACA GTACTGTTAA 240 GGGTGGCTTA AATAAGCAAC AACAGTTTCT CAATTTGAGA TGACACAAAC TCCCCCCACC 300 CCCAGAAAAG CAGAAGCATT CTTTCTAAAT TTTCTCTCAA CTTTCTGGAG TTTCTAAATT 360 TTCCCCCACA CTCTGCTCTA CCATCATACC AATCTCACAA AAGATGCAGT CATGAGGGCC 420 TGAGAAATCA CACAGTTTTG TGCTCCTAAT TTTCTTCTCC AAATACAAAG AAGAAAATGC 480 TGCATATCAT TCATAATTAC TCAATTTTTA TTGCTCAGGA CACCCACTTA CTCATTTGAT 540 ATACATATTG AAGGTCTGCT ATATACCAGG CACTCTTCTA GTTACTGGGG ATAGGGCAGC 600 AAACAAAGCA GACAAAGTCC TTCTTCTGAT GCTTCTTAGA TTTTAGGGTA GCAGATCCTA 660 GAAGGAAAAA ATAATAATAA GGCAGGGTAA GGAGATAGAG AGTAAAAGAT CAGGGAGTGA 720 TGTTCTATAG GGGCACAGGA GCCCCTGTCT GATAGGTGAC ACTGAGTAGA TCTCAAGAAA 780 GAGATAGCCA TATGGTCATC TGGGGAAGGG CCCTCCTCTA GTGCAAAAGC TTTGGAGTGT 840 GCTTGGAATA TTCAAGAACA TTGAGGTGGT TAGTGTGACA GGTGTGGAAT ACGTCAGGGG 900 AAAGTGATGG GAGATGACAT TAAAAAGGTA GCCAAGAACC ATCATATGGG GTCTTGGAGG 960 CCCTGGGAAG AAGTTTGTAT TTTATTCAAA GAGCTATGGG AGACAACTGG CAAGCAGAGG 1020 AACAACATGA TCTGACTTAT GTGTTTAAAG AATCACTTTA GTAGCCTGTG AAAAATACAT 1080 TATAGGGGAC AAAGATAGAG GCAAGGAGAC TAGTTAGGCG GCTGTTGCAG TAGTGCAGGT 1140 GAGAGATGGT AGTGGCGAAG GTGGTGAAGG CAATGAGAAG TTATCAGGTT CTAGGCATTT 1200 TTTCCAAGGC AAAGTCAATA GAATTTTCTG ATGGATGGAT ATGGGGATAA GAAAGGGGAG 1260 TCATGGATAA TTATAATTTT CTGTCCTGAA AACCTGAGTG ATTGGAGCTG CAGTTTACTG 1320 AGTTGGAGAA CACAGATGGA GGAGGAGGTA GAAGGTAGGC AAACAGGAGT TTGATTGGCA 1380 CATGTGAAGT TTTAGATGCC TTTTAAATAT CCAAATGGAG ATTCTGAGTA GGTAGCTGGA 1440 TATACAAGAC TTGAATTCAA GAAAAAGGTT ACAGTTGGAA ATAAAATTTG GTATTTCAAA 1500 CCAAGAGACT GAATGAGATC ACCTAAGGAA TCAGGATAGA TTAAAAAATG AGTAAGTCTA 1560 AGGACTGAAC CCAGAGACAT TTTCCATTGC TATAAAGGAA TACCCAAGAC TGGGTAATTT 1620 ATAAAGAAAA GAGGTTTATT TGGCTCATGA TTCTGCAAGC TGTACAAGAA TGGCACGTGT 1680 ATCTGCTCAG CTTCTGGTGA GGGCTTCAGG AAGCTTACAA TCATGGCAGA AAATGAAGAG 1740 GAGCAGGCAT GTCATATGGT GAGAGAGGGA GAAAAAGAGA GAGGGGAGAA GGCACCAGGC 1800 TCTTTTAAAC AACCAGCTCT CACATGAACT AATAGGGCGA AATCTCACTT ATTACTATGG 1860 GGAGGGCAAC AAGCCATTCA TGAGGGATCC ACCCTCATGA CCCAAACACT TCCCACTAGG 1920 CCCCATCTCC AACACTGGGG ATCACATTCC AATGTGAGAT TTGGAGGGAA TAAATATCCA 1980 AACCATATCA CTTGGGAAGG AAGGAACCAA GAGAGAGTAC AGTCTCATGG GCCAAAATGT 2040 CTCAAGAAAG AGGGAATGAT TAACTACCAA ATGCTTTTAA TTAAATTTTA 2090
|